Analysts’ Views on Endo International and Mallinckrodt

Stock movement

On March 5, Endo International (ENDP) closed at $8.72, 6.54% lower than its previous closing price, 65.46% higher than its 52-week low of $5.27, and 52.86% below its 52-week high of $18.50. The company’s market capitalization was $1.84 billion, and its forward PE ratio was 3.08x.

Endo released its fourth-quarter earnings results on February 28. Between February 27 and March 5, its stock fell 15.67% from $10.34. However, it beat analysts’ average revenue and EPS estimates by $47.87 million and $0.16, respectively, in the fourth quarter.

Mallinckrodt (MNK) closed at $22.39 on March 5, 3.70% lower than its previous closing price, 92.19% higher than its 52-week low of $11.65, and 38.91% below its 52-week high of $36.65. The company’s market capitalization was $1.83 billion, and its forward PE ratio was 2.83x.

Mallinckrodt released its fourth-quarter earnings results on February 26. Between February 25 and March 5, its stock rose 3.85% from $21.56. The company beat analysts’ average revenue and EPS estimates by $156.69 million and $0.20, respectively, in the fourth quarter. Mallinckrodt’s forward PE ratio is lower than Endo’s.

Analysts’ Views on Endo International and MallinckrodtAnalysts’ recommendations and target prices

Most analysts covering Endo International and Mallinckrodt recommend “hold.” Of the 16 analysts covering Endo, two recommend “strong buy,” two recommend “buy,” and 12 recommend “hold.” Their 12-month target price is $15.23, 74.66% higher than its March 5 closing price. Their highest, median, and lowest target prices for the stock are $24, $16, and $9, respectively.

Of the 16 analysts covering Mallinckrodt, two recommend “strong buy,” three recommend “buy,” eight recommend “hold,” and three recommend “sell.” Their 12-month target price is $29.50, 31.76% higher than its March 5 closing price. Their highest, median, and lowest target prices for the stock are $42, $29, and $14, respectively. Next, we’ll look at Endo’s and Mallinckrodt’s revenue growth trajectory.